Mobile

A double-blind, multicentric, multinational randomised study to assess the effects of two years administration of 2 g per day of strontium ranelate versus alendronate 70 mg per week in women with post...

Mise à jour : Il y a 4 ans
Référence : EUCTR2007-001509-11

A double-blind, multicentric, multinational randomised study to assess the effects of two years administration of 2 g per day of strontium ranelate versus alendronate 70 mg per week in women with postmenopausal osteoporosis on bone geometry and bone strength measured by peripheral-Quantitative Computed Tomography (p-QCT)

Femme Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

To assess the effects of strontium ranelate in comparison with alendronate (both treatment with calcium and vitamin D supplement) on the bone geometry and bone strength in postmenopausal osteoporotic women.

Critère d'inclusion

  • Post Menopausal Osteoporosis

Liens